Christian M Capitini

Summary

Affiliation: University of Wisconsin
Country: USA

Publications

  1. pmc Graft-versus-host disease impairs vaccine responses through decreased CD4+ and CD8+ T cell proliferation and increased perforin-mediated CD8+ T cell apoptosis
    Christian M Capitini
    Blood and Marrow Transplant Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Immunol 190:1351-9. 2013
  2. pmc Extracorporeal photopheresis attenuates murine graft-versus-host disease via bone marrow-derived interleukin-10 and preserves responses to dendritic cell vaccination
    Christian M Capitini
    Immunology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Biol Blood Marrow Transplant 17:790-9. 2011
  3. pmc Immunotherapy of childhood cancer: from biologic understanding to clinical application
    Alan S Wayne
    Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Room 1 3750, 9000 Rockville Pike, MSC 1104, Bethesda, MD 20892 1104, USA
    Curr Opin Pediatr 22:2-11. 2010
  4. pmc Immune-based therapeutics for pediatric cancer
    Christian M Capitini
    National Cancer Institute, National Institutes of Health, Center for Cancer Research, Pediatric Oncology Branch, 10 Center Drive, MSC 1104, Bethesda, MD 20892, USA
    Expert Opin Biol Ther 10:163-78. 2010
  5. doi request reprint Highlights of the second international conference on "Immunotherapy in Pediatric Oncology"
    Christian M Capitini
    Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
    Pediatr Hematol Oncol 28:459-60. 2011
  6. pmc Bone marrow deficient in IFN-{gamma} signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effect
    Christian M Capitini
    Immunology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Blood 113:5002-9. 2009

Detail Information

Publications6

  1. pmc Graft-versus-host disease impairs vaccine responses through decreased CD4+ and CD8+ T cell proliferation and increased perforin-mediated CD8+ T cell apoptosis
    Christian M Capitini
    Blood and Marrow Transplant Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Immunol 190:1351-9. 2013
    ..These results provide important insights toward optimizing vaccine responses after allogeneic BMT...
  2. pmc Extracorporeal photopheresis attenuates murine graft-versus-host disease via bone marrow-derived interleukin-10 and preserves responses to dendritic cell vaccination
    Christian M Capitini
    Immunology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Biol Blood Marrow Transplant 17:790-9. 2011
    ..Importantly, the attenuation of GVHD by ECP-treated splenocytes permits donor lymphocyte infusion-dependent responses to DC vaccines after allo-BMT...
  3. pmc Immunotherapy of childhood cancer: from biologic understanding to clinical application
    Alan S Wayne
    Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Room 1 3750, 9000 Rockville Pike, MSC 1104, Bethesda, MD 20892 1104, USA
    Curr Opin Pediatr 22:2-11. 2010
    ..This review summarizes the biologic basis of cancer immunotherapy and highlights recent examples of progress in the application of novel humoral and cellular immunotherapies to children and adolescents with malignancy...
  4. pmc Immune-based therapeutics for pediatric cancer
    Christian M Capitini
    National Cancer Institute, National Institutes of Health, Center for Cancer Research, Pediatric Oncology Branch, 10 Center Drive, MSC 1104, Bethesda, MD 20892, USA
    Expert Opin Biol Ther 10:163-78. 2010
    ..Elucidation of the principles of tumor biology and the development of novel laboratory technologies over the last decade have led to substantial progress in bringing immunotherapies to the bedside...
  5. doi request reprint Highlights of the second international conference on "Immunotherapy in Pediatric Oncology"
    Christian M Capitini
    Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
    Pediatr Hematol Oncol 28:459-60. 2011
    ..The resulting discussions will hopefully lead to new collaborations and insight for further translational and clinical studies...
  6. pmc Bone marrow deficient in IFN-{gamma} signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effect
    Christian M Capitini
    Immunology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Blood 113:5002-9. 2009
    ....